Clinical Trial For LU-177 PSMA Metastatic PCa
I just emailed the principle investigator and they are recruiting now
I participated in this trial at Excel Diagnostics. Unfortunately it did not work for me. I withdrew from the trial after two treatments as scans showed desease progression and my PSA did not decline.
Were you given information on the costs to participate? If so, please share.
The PSMA scan cost $5k and the LU177 treatment is $10.5k/treatment.
I was inquiring about this phase II trial that’s still open at UCLA, and Texas, and I got this reply back:
Phase II- Insurance is most probably not covering costs as is it not FDA approved, however, the phase 3 trial will be paid for by the company Endocyte.
UCLA Nuclear Medicine
310 206 73 72 (office)
310 206 48 99 (fax)
have been following this site for almost a year now. We are so impressed by all of you and your posts...
Many are interested in this trial. I just received notice that it is temporarily suspended. The problem...